Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Fimbrion Therapeutics and GlaxoSmithKline describe Escherichia coli FimH inhibitors

Jan. 31, 2020

Inovio and Beijing Advaccine collaborate to advance new vaccine against new coronavirus in China

Jan. 31, 2020

Cynomolgus macaque Marburg virus model developed using aerosol exposure

Jan. 30, 2020

CNRS and collaborators patent compounds for RNA virus infections

Jan. 30, 2020

Novel coronavirus emerges rapidly; so does science

Jan. 30, 2020

H84T engineered banana lectin shows efficacy in influenza virus infection models

Jan. 30, 2020

Spring Bank discontinues development of inarigivir and all HBV programs

Jan. 30, 2020

Novel cynomolgus macaque model for Sudan virus disease

Jan. 30, 2020

CytoDyn explores use of leronlimab for novel coronavirus

Jan. 29, 2020

Blueberry Therapeutics receives IND clearance from the FDA for BB-2603

Jan. 29, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...